Authors: SOIGNET SL MASLAK P CHEN YW CALLEJA E PANDOLFI PP SCHEINBERG DA WARRELL RP

Citation: Sl. Soignet et al., WESTERN STUDY OF ARSENIC TRIOXIDE (AS2O3) IN PATIENTS WITH RELAPSED AND OR REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA/, Annals of oncology, 9, 1998, pp. 675-675

Authors: SOIGNET SL BENEDETTI F FLEISCHAUER A PARKER BA TRUGLIA JA CRISP MR WARRELL RP

Citation: Sl. Soignet et al., CLINICAL-STUDY OF 9-CIS RETINOIC ACID (LGD1057) IN ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia, 12(10), 1998, pp. 1518-1521

Authors: SOIGNET SL MASLAK P WANG ZG JHANWAR S CALLEJA E DARDASHTI LJ CORSO D DEBLASIO A GABRILOVE J SCHEINBERG DA PANDOLFI PP WARRELL RP

Citation: Sl. Soignet et al., COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE, The New England journal of medicine, 339(19), 1998, pp. 1341-1348

Authors: SOIGNET SL MASLAK P CHEN YW CALLEJA E PANDOLFI PP SCHEINBERG DA WARRELL RP

Citation: Sl. Soignet et al., COMPLETE REMISSION AFTER CLINICALLY INDUCED-DIFFERENTIATION AND APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA BY ARSENIC TRIOXIDE, British Journal of Haematology, 102(1), 1998, pp. 225-225

Authors: SOIGNET SL RIVI R KONIG A TONG WP GABRILOVE J SCHEINBERG DA PANDOLFI PP WARRELL RP

Citation: Sl. Soignet et al., MELARSOPROL, AN ORGANIC ARSENICAL, IN THE TREATMENT OF REFRACTORY LEUKEMIA - LABORATORY AND CLINICAL-RESULTS, Blood, 90(10), 1997, pp. 2258-2258